Decreased Srcasm expression in esophageal squamous cell carcinoma in a Chinese population

Yu Qi1, Xin Li, Liang Zhao

  • 1Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, PRC. ekansqy@gmail.com

Anticancer Research
|October 15, 2010
PubMed
Abstract

Insights

Srcasm protein expression is decreased in esophageal squamous cell carcinoma (SCC) compared to normal tissue. This suggests Srcasm may function as a negative regulator in esophageal SCC cell signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Src-family tyrosine kinases (SFKs) are crucial for cell differentiation and proliferation.
  • Src-activating and signaling molecule (Srcasm) down-regulates SFK activity and promotes cell differentiation.

Purpose of the Study:

  • To investigate alterations in Srcasm expression in esophageal squamous cell carcinoma (SCC) versus normal esophageal epithelium in a Chinese population.

Main Methods:

  • Immunohistochemical staining was used to examine Srcasm expression.
  • 30 paired samples of normal esophageal epithelium and SCC from the same patient were analyzed.

Main Results:

  • Srcasm protein expression levels were significantly decreased in esophageal SCC tissues.
  • A notable reduction in Srcasm was observed when compared to adjacent normal esophageal epithelium.

Conclusions:

  • The diminished Srcasm expression in esophageal SCC suggests a potential role as a tumor suppressor.
  • Srcasm may act as a negative regulator in esophageal SCC cell signaling pathways.

Related Concept Videos

Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Esophagus01:24

Esophagus

The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...